-->

HTRF Human Phospho-TYK2 Tyr1054/1055 Detection Kit HTRF®

This HTRF kit enables the cell-based quantitative detection of phosphorylated TYK2 at Tyr1054/1055, as a readout of cytokine receptor activation.

See more
  • No-wash No-wash
  • High sensitivity High sensitivity
  • All inclusive kit All inclusive kit
  • Low sample consumption Low sample consumption

This HTRF kit enables the cell-based quantitative detection of phosphorylated TYK2 at Tyr1054/1055, as a readout of cytokine receptor activation.

-

Overview

TYK2 (Tyrosine kinase 2) belongs to the family of non-receptor Janus tyrosine kinases with JAK1, JAK2, and JAK3. A wide array of cytokines and growth factors (Interferons, IL12, IL23) attached to their receptors induce the phosphorylation of TYK2. The activated TYK2 subsequently phosphorylate additional targets, including both the cytokine receptors and the major substrates: STATs.  The JAKs/STATs signaling stimulates cell proliferation, differentiation, migration, and apoptosis. Altering JAK/STATs signaling to reduce cytokine induced pro-inflammatory responses represents an attractive target for anti-inflammatory therapies.

Benefits

  • SPECIFICITY
  • PRECISION

Phospho-TYK2 (Tyr1054/1055) assay principle

The Phospho-TYK2 (Tyr1054/1055) assay measures TYK2 when phosphorylated at Tyr1054/1055. Unlike Western Blot, the assay is entirely plate-based and does not require gels, electrophoresis, or transfer. The Phospho-TYK2 (Tyr1054/1055) assay uses 2 labeled antibodies: one with a donor fluorophore, the other with an acceptor. The first antibody was selected for its specific binding to the phosphorylated motif on the protein, the second for its ability to recognize the protein independent of its phosphorylation state. Protein phosphorylation enables an immune-complex formation involving both labeled antibodies and which brings the donor fluorophore into close proximity to the acceptor, thereby generating a FRET signal. Its intensity is directly proportional to the concentration of phosphorylated protein present in the sample, and provides a means of assessing the protein’s phosphorylation state under a no-wash assay format.

Principle of the HTRF TYK2 p-Y1054/1055 assay

Phospho-TYK2 (Tyr1054/1055) 2-plate assay protocol

The 2 plate protocol involves culturing cells in a 96-well plate before lysis, then transferring lysates into a 384-well low volume detection plate before adding Phospho-TYK2 (Tyr1054/1055) HTRF detection reagents. This protocol enables the cells' viability and confluence to be monitored.

Two-plate protocol of the HTRF TYK2-pY1054/1055 assay principle

Phospho-TYK2 (Tyr1054/1055) 1-plate assay protocol

Detection of Phosphorylated TYK2 (Tyr1054/1055) with HTRF reagents can be performed in a single plate used for culturing, stimulation, and lysis. No washing steps are required. This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.

One-plate protocol of the HTRF TYK2 p-Y1054/1055 assay

Phospho TYK2 (Tyr1054/1055) activation on HEL92.1.7 cells

HEL92.1.7 cells (Human erythroleukaemia) were seeded in a half area 96-well culture-treated plate at 400,000 cells / well in 25 µL complete culture medium and incubated overnight. Cells were then treated with 5 µL of increasing concentrations of Interferons for 15 minutes . After treatment, cells were lysed with 10µl of supplemented lysis buffer # 4 (4X) for 30 min at RT under gentle shaking.

After cell lysis, 16 µL of lysate were transferred into a 384-well low volume white microplate, and 4 µL of the HTRF phospho-TYK2 (Tyr1054/1055) detection reagents were added. The HTRF signal was recorded after an overnight incubation at room temperature.

As expected, the results obtained show a dose-response stimulation of TYK2 Y1054/1055 phosphorylation upon treatment with Interferons.

Validation of TYK2 kits on HEL92.1.7 cells

Phospho TYK2 (Tyr1054/1055) Inhibition on Hela cells

Hela cells (cervical cancer) were plated in 96-well culture-treated plate (200,000 cells/well) in complete culture medium, and incubated overnight at 37°C,5%CO2. Cells were treated with a dose-response of Deucravacitinib (BMS-986165) 3h at 37 °C, 5% CO2. Cells were stimulated with pervanadate 100 µM and IFN beta 1nM for 1 hour at 37°C,5%CO2. Cells were then lysed with 50 µl of supplemented lysis buffer #4 (1X) for 30 min at RT under gentle shaking. After cell lysis, 16 µL of lysate were transferred into a 384-well low volume white microplate and 4 µL of the HTRF Phospho-TYK2 (Tyr1054/1055) or Total-TYK2 detection reagents were added. The HTRF signal was recorded after an overnight incubation at room temperature.

As expected, Deucravacitinib induced a dose-dependent decrease of TYK2 phosphorylation, without effect on the expression level of the total protein.

Validation of TYK2 kits on Hela cells

Phospho TYK2 (Tyr1054/1055) Inhibition on HEL92.1.7 cells

HEL92.1.7 cells (Human erythroleukaemia) were seeded in a half area 96-well culture-treated plate at 400,000 cells / well in 20 µL complete culture medium and incubated overnight. Cells were treated with 5µL of a dose-response of Deucravacitinib (BMS-986165) 3h at 37 °C, 5% CO2 then with IFN beta 1nM for 15mn at 37°C,5%CO2. Cells were then lysed with 50 µl of supplemented lysis buffer #4 (1X) for 30 min at RT under gentle shaking. After cell lysis, 16 µL of lysate were transferred into a 384-well low volume white microplate and 4 µL of the HTRF Phospho-TYK2 (Tyr1054/1055) or Total-TYK2 detection reagents were added. The HTRF signal was recorded after an overnight incubation at room temperature.

As expected, Deucravacitinib induced a dose-dependent decrease of TYK2 phosphorylation, without effect on the expression level of the total protein.

Validation of TYK2 kits on HEL92.1.7 cells

HTRF Phospho TYK2 (Tyr1054/1055) Assay compared to Western Blot

Hela cells were cultured in a T175 flask in complete culture medium at 37°C, 5% CO2. After 72h incubation, the cells were first stimulated with pervanadate 100 µM and IFN alpha 2 5nM, then lysed with 3 mL of supplemented lysis buffer #4 (1X) for 30 minutes at RT under gentle shaking.

Serial dilutions of the cell lysate were performed using supplemented lysis buffer, and 16 µL of each dilution were transferred into a low volume white microplate before the addition of 4 µL of HTRF Phospho-TYK2 (Tyr1054/1055) detection reagents. Equal amounts of lysates were used for a side by side comparison between HTRF and Western Blot.

A side by side comparison of Western Blot and HTRF demonstrates that the HTRF assay is 4-fold more sensitive than the Western Blot, at least under these experimental conditions.

Comparison of HTRF TYK2 p-Y1054/1055 kit with Western Blot

Simplified pathway of TYK2 signaling

TYK2 in combination with JAK1, JAK2, or JAK3 interacts with different types of cytokine/interferon receptors (IL2, IL23, IFN alpha and beta). Upon cytokine activation, TYK2 and the other members of the JAK family transphosphorylate each other, and then activate the transcription factors STAT1, STAT2, STAT3, and STAT6, which dimerize. They then translocate to the nucleus to trigger the transcription of genes regulating cell differentiation, proliferation, survival, and adapted immune response.

TYK2 signaling pathway

HTRF cellular phospho-protein assays

Physiologically relevant results fo fast flowing research - Flyers

Best practices for analyzing brain samples with HTRF® phospho assays for neurosciences

Insider Tips for successful sample treatment - Technical Notes

Optimize your HTRF cell signaling assays on tissues

HTRF and WB compatible guidelines - Technical Notes

Best practices for analyzing tumor xenografts with HTRF phospho assays

Protocol for tumor xenograft analysis with HTRF - Technical Notes

Key guidelines to successful cell signaling experiments

Mastering the art of cell signaling assays optimization - Guides

HTRF® cell signaling platform combined with iCell® Hepatocytes

A solution for phospho-protein analysis in metabolic disorders - Posters

HTRF phospho-assays reveal subtle drug-induced effects

Detailed protocol and direct comparison with WB - Posters

Universal HTRF® phospho-protein platform: from 2D, 3D, primary cells to patient derived tumor cells

Analysis of a large panel of diverse biological samples and cellular models - Posters

HTRF phospho assays reveal subtle drug induced effects in tumor-xenografts

Tumor xenograft analysis: HTRF versus Western blot - Application Notes

HTRF cell-based phospho-protein data normalization

Valuable guidelines for efficiently analyzing and interpreting results - Application Notes

HTRF phospho-total lysis buffer: a universal alternative to RIPA lysis buffers

Increased flexibility of phospho-assays - Application Notes

HTRF Alpha-tubulin Housekeeping kit

Properly interpret your compound effect - Application Notes

Simplified pathway dissection with HTRF phospho-assays and CyBi-felix liquid handling

Analyse of PI3K/AKT/mTor translational control pathway - Application Notes

How to run a cell based phospho HTRF assay

What to expect at the bench - Videos

Unleash the potential of your phosphorylation research with HTRF

A fun video introducing you to phosphorylation assays with HTRF - Videos

How to run a cell based phospho HTRF assay

3' video to set up your Phospho assay - Videos

Guidelines for Cell Culture and Lysis in Different Formats Prior to HTRF Detection

Seeding and lysing recommendations for a number of cell culture vessels. - Technical Notes

Product Insert TYK2 p-Y1054/55 Kit / 64TYK2Y10PEG-64TYK2Y10PEH

64TYK2Y10PEG-64TYK2Y10PEH - Product Insert

Assessment of drug efficacy and toxicity by combining innovative technologies

Combination of AlphaLISA®, HTRF®, or AlphaLISA® SureFire® Ultra™ immunoassays with the ATPlite™ 1step cell viability assay - Application Notes

Methodological Aspects of Homogeneous Time-Resolved Fluorescence (HTRF)

Learn how to reduce time and sample consumption - Application Notes

Plate Reader Requirement

Choosing the right microplate reader ensures you’ll get an optimal readout. Discover our high performance reader, or verify if your lab equipment is going to be compatible with this detection technology.

Let's find your reader